Financial Snapshot

Revenue
$32.53B
TTM
Gross Margin
60.39%
TTM
Net Earnings
$4.230B
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
131.77%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
$79.37B
Q3 2024
Book Value
$11.52B
Q3 2024
Cash
Q3 2024
P/E
35.36
Nov 29, 2024 EST
Free Cash Flow
$6.283B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982
Revenue $28.19B $26.32B $25.98B $25.42B $23.36B $23.75B $22.85B $22.99B $21.66B $20.06B $18.68B $17.27B $15.58B $15.05B $14.64B $15.00B $14.77B $14.27B $12.43B $10.55B $8.356B $5.523B $4.016B $3.629B $3.340B $2.718B $2.401B $2.240B $1.940B $1.648B $1.374B $1.093B $682.0M $299.0M $148.0M $70.00M $44.00M $30.00M $23.00M $10.00M $3.000M $0.00
YoY Change 7.09% 1.32% 2.18% 8.83% -1.62% 3.93% -0.62% 6.14% 7.97% 7.43% 8.17% 10.8% 3.51% 2.81% -2.41% 1.57% 3.53% 14.79% 17.82% 26.26% 51.29% 37.52% 10.66% 8.65% 22.88% 13.2% 7.19% 15.46% 17.72% 19.94% 25.71% 60.26% 128.09% 102.03% 111.43% 59.09% 46.67% 30.43% 130.0% 233.33%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982
Revenue $28.19B $26.32B $25.98B $25.42B $23.36B $23.75B $22.85B $22.99B $21.66B $20.06B $18.68B $17.27B $15.58B $15.05B $14.64B $15.00B $14.77B $14.27B $12.43B $10.55B $8.356B $5.523B $4.016B $3.629B $3.340B $2.718B $2.401B $2.240B $1.940B $1.648B $1.374B $1.093B $682.0M $299.0M $148.0M $70.00M $44.00M $30.00M $23.00M $10.00M $3.000M $0.00
Cost Of Revenue $8.415B $6.406B $6.454B $6.159B $4.356B $4.101B $4.069B $4.162B $4.227B $4.422B $3.346B $3.199B $2.708B $2.220B $2.091B $2.296B $2.548B $2.095B $2.082B $1.731B $1.341B $736.0M $443.0M $408.0M $402.0M $345.0M $301.0M $283.0M $273.0M $238.0M $220.0M $185.0M $113.0M $61.00M $17.00M $1.000M $0.00 $0.00 $0.00 $0.00
Gross Profit $19.78B $19.92B $19.53B $19.27B $19.01B $19.65B $18.78B $18.83B $17.44B $15.64B $15.33B $14.07B $12.87B $12.83B $12.55B $12.71B $12.22B $12.17B $10.35B $8.819B $7.015B $4.787B $3.573B $3.221B $2.938B $2.373B $2.100B $1.957B $1.667B $1.410B $1.154B $908.0M $569.0M $238.0M $130.0M $70.00M $44.00M $30.00M $3.000M $0.00
Gross Profit Margin 70.15% 75.66% 75.16% 75.77% 81.35% 82.73% 82.19% 81.9% 80.49% 77.96% 82.08% 81.47% 82.62% 85.25% 85.72% 84.7% 82.75% 85.32% 83.25% 83.59% 83.95% 86.67% 88.97% 88.76% 87.96% 87.31% 87.46% 87.37% 85.93% 85.56% 83.99% 83.07% 83.43% 79.6% 87.84% 100.0% 100.0% 100.0% 100.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982
Selling, General & Admin $5.518B $5.270B $5.368B $5.730B $5.150B $5.332B $4.870B $5.062B $4.846B $4.699B $5.184B $4.814B $4.499B $3.983B $2.579B $3.861B $3.412B $3.427B $2.848B $2.581B $1.953B $1.462B $971.0M $827.0M $654.0M $515.0M $484.0M $471.0M $418.0M $360.0M $328.0M $292.0M $203.0M $101.0M $58.00M $23.00M $10.00M $7.000M $5.000M $3.000M $2.000M $1.000M
YoY Change 4.71% -1.83% -6.32% 11.26% -3.41% 9.49% -3.79% 4.46% 3.13% -9.36% 7.69% 7.0% 12.96% 54.44% -33.2% 13.16% -0.44% 20.33% 10.34% 32.16% 33.58% 50.57% 17.41% 26.45% 26.99% 6.4% 2.76% 12.68% 16.11% 9.76% 12.33% 43.84% 100.99% 74.14% 152.17% 130.0% 42.86% 40.0% 66.67% 50.0% 100.0%
% of Gross Profit 27.9% 26.46% 27.49% 29.74% 27.1% 27.14% 25.93% 26.88% 27.79% 30.04% 33.82% 34.22% 34.95% 31.04% 20.55% 30.38% 27.91% 28.15% 27.52% 29.27% 27.84% 30.54% 27.18% 25.68% 22.26% 21.7% 23.05% 24.07% 25.07% 25.53% 28.42% 32.16% 35.68% 42.44% 44.62% 32.86% 22.73% 23.33% 66.67%
Research & Development $4.700B $4.341B $4.819B $4.207B $4.116B $3.737B $3.562B $3.840B $4.070B $4.297B $4.083B $3.380B $3.167B $2.894B $2.864B $3.030B $3.266B $3.366B $2.314B $2.028B $1.655B $1.117B $865.0M $845.0M $823.0M $663.0M $631.0M $528.0M $452.0M $324.0M $255.0M $182.0M $121.0M $72.00M $63.00M $51.00M $39.00M $24.00M $17.00M $14.00M $9.000M $7.000M
YoY Change 8.27% -9.92% 14.55% 2.21% 10.14% 4.91% -7.24% -5.65% -5.28% 5.24% 20.8% 6.73% 9.43% 1.05% -5.48% -7.23% -2.97% 45.46% 14.1% 22.54% 48.16% 29.13% 2.37% 2.67% 24.13% 5.07% 19.51% 16.81% 39.51% 27.06% 40.11% 50.41% 68.06% 14.29% 23.53% 30.77% 62.5% 41.18% 21.43% 55.56% 28.57%
% of Gross Profit 23.77% 21.8% 24.68% 21.84% 21.66% 19.02% 18.97% 20.39% 23.34% 27.47% 26.63% 24.03% 24.6% 22.55% 22.82% 23.85% 26.72% 27.65% 22.36% 23.0% 23.59% 23.33% 24.21% 26.23% 28.01% 27.94% 30.05% 26.98% 27.11% 22.98% 22.1% 20.04% 21.27% 30.25% 48.46% 72.86% 88.64% 80.0% 300.0%
Depreciation & Amortization $55.00M $237.0M $3.398B $3.601B $2.206B $1.946B $1.955B $2.105B $2.108B $2.092B $1.286B $1.088B $1.060B $1.017B $1.049B $1.073B $1.202B $963.0M $841.0M $734.0M $687.0M $447.0M $266.0M $212.0M $177.0M $144.0M $117.0M $100.0M $84.00M $75.00M $51.00M $34.00M $21.00M $16.00M $11.00M $8.000M $4.000M $3.000M $3.000M
YoY Change -76.79% -93.03% -5.64% 63.24% 13.36% -0.46% -7.13% -0.14% 0.76% 62.67% 18.2% 2.64% 4.23% -3.05% -2.24% -10.73% 24.82% 14.51% 14.58% 6.84% 53.69% 68.05% 25.47% 19.77% 22.92% 23.08% 17.0% 19.05% 12.0% 47.06% 50.0% 61.9% 31.25% 45.45% 37.5% 100.0% 33.33% 0.0%
% of Gross Profit 0.28% 1.19% 17.4% 18.69% 11.61% 9.91% 10.41% 11.18% 12.09% 13.38% 8.39% 7.73% 8.23% 7.92% 8.36% 8.44% 9.83% 7.91% 8.13% 8.32% 9.79% 9.34% 7.44% 6.58% 6.02% 6.07% 5.57% 5.11% 5.04% 5.32% 4.42% 3.74% 3.69% 6.72% 8.46% 11.43% 9.09% 10.0%
Operating Expenses $10.27B $10.35B $10.19B $9.937B $9.266B $9.069B $8.432B $8.902B $8.916B $8.996B $9.267B $8.194B $7.666B $6.877B $5.746B $7.185B $6.976B $7.163B $5.509B $4.942B $3.920B $2.593B $2.039B $1.623B $1.428B $1.156B $1.272B $999.0M $870.0M $684.0M $570.0M $397.0M $452.0M $173.0M $121.0M $74.00M $50.00M $31.00M $22.00M $17.00M $11.00M $9.000M
YoY Change -0.75% 1.61% 2.52% 7.24% 2.17% 7.55% -5.28% -0.16% -0.89% -2.92% 13.09% 6.89% 11.47% 19.68% -20.03% 3.0% -2.61% 30.02% 11.47% 26.07% 51.18% 27.17% 25.63% 13.66% 23.53% -9.12% 27.33% 14.83% 27.19% 20.0% 43.58% -12.17% 161.27% 42.98% 63.51% 48.0% 61.29% 40.91% 29.41% 54.55% 22.22%
Operating Profit $9.502B $9.566B $7.639B $9.139B $9.674B $10.26B $9.973B $9.794B $8.470B $6.191B $5.867B $5.577B $4.312B $5.545B $6.805B $5.522B $5.247B $5.010B $4.839B $3.877B $3.095B $2.194B $1.534B $1.598B $1.510B $1.217B $828.0M $958.0M $797.0M $726.0M $584.0M $511.0M $117.0M $65.00M $9.000M -$4.000M -$6.000M -$1.000M -$8.000M -$9.000M
YoY Change -0.67% 25.23% -16.41% -5.53% -5.74% 2.91% 1.83% 15.63% 36.81% 5.52% 5.2% 29.34% -22.24% -18.52% 23.23% 5.24% 4.73% 3.53% 24.81% 25.27% 41.07% 43.02% -4.01% 5.83% 24.08% 46.98% -13.57% 20.2% 9.78% 24.32% 14.29% 336.75% 80.0% 622.22% -325.0% -33.33% 500.0% -11.11%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982
Interest Expense -$1.353B -$1.406B -$1.197B -$1.006B -$536.0M -$798.0M -$376.0M -$631.0M -$492.0M -$606.0M -$602.0M -$568.0M -$162.0M -$1.341B -$1.393B -$127.0M -$136.0M $241.0M $78.00M $72.00M $78.00M $113.0M $152.0M $106.0M $56.00M $7.000M $33.00M $4.000M -$2.000M -$22.00M $8.000M $52.00M $41.00M $15.00M $2.000M -$2.000M $8.000M $3.000M -$1.000M -$1.000M $3.000M $1.000M
YoY Change -3.77% 17.46% 18.99% 87.69% -32.83% 112.23% -40.41% 28.25% -18.81% 0.66% 5.99% 250.62% -87.92% -3.73% 996.85% -6.62% -156.43% 208.97% 8.33% -7.69% -30.97% -25.66% 43.4% 89.29% 700.0% -78.79% 725.0% -300.0% -90.91% -375.0% -84.62% 26.83% 173.33% 650.0% -200.0% -125.0% 166.67% -400.0% 0.0% -133.33% 200.0%
% of Operating Profit -14.24% -14.7% -15.67% -11.01% -5.54% -7.78% -3.77% -6.44% -5.81% -9.79% -10.26% -10.18% -3.76% -24.18% -20.47% -2.3% -2.59% 4.81% 1.61% 1.86% 2.52% 5.15% 9.91% 6.63% 3.71% 0.58% 3.99% 0.42% -0.25% -3.03% 1.37% 10.18% 35.04% 23.08% 22.22%
Other Income/Expense, Net $1.311B -$814.0M $259.0M $256.0M $753.0M $674.0M $928.0M $629.0M $603.0M $465.0M $420.0M $485.0M $448.0M $376.0M
YoY Change -261.06% -414.29% 1.17% -66.0% 11.72% -27.37% 47.54% 4.31% 29.68% 10.71% -13.4% 8.26% 19.15%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982
Pretax Income $7.855B $7.346B $6.701B $8.133B $9.138B $9.545B $9.597B $9.163B $7.978B $5.585B $5.265B $5.009B $4.150B $5.317B $5.204B $5.015B $3.793B $4.020B $4.868B $3.395B $3.173B -$685.0M $1.686B $1.674B $1.566B $1.224B $861.0M $962.0M $794.0M $588.0M $592.0M $563.0M $158.0M $24.00M $11.00M -$7.000M $2.000M $2.000M $1.000M -$8.000M -$5.000M -$7.000M
YoY Change 6.93% 9.63% -17.61% -11.0% -4.26% -0.54% 4.74% 14.85% 42.85% 6.08% 5.11% 20.7% -21.95% 2.17% 3.77% 32.22% -5.65% -17.42% 43.39% 7.0% -563.21% -140.63% 0.72% 6.9% 27.94% 42.16% -10.5% 21.16% 35.03% -0.68% 5.15% 256.33% 558.33% 118.18% -257.14% -450.0% 0.0% 100.0% -112.5% 60.0% -28.57%
Income Tax $1.138B $794.0M $808.0M $869.0M $1.296B $1.151B $7.618B $1.441B $1.039B $427.0M $184.0M $664.0M $467.0M $690.0M $599.0M $963.0M $715.0M $1.070B $1.194B $1.032B $914.0M $707.0M $567.0M $536.0M $470.0M $361.0M $217.0M $283.0M $257.0M $269.0M $218.0M $206.0M $60.00M $20.00M $7.000M $1.000M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 14.49% 10.81% 12.06% 10.68% 14.18% 12.06% 79.38% 15.73% 13.02% 7.65% 3.49% 13.26% 11.25% 12.98% 11.51% 19.2% 18.85% 26.62% 24.53% 30.4% 28.81% 33.63% 32.02% 30.01% 29.49% 25.2% 29.42% 32.37% 45.75% 36.82% 36.59% 37.97% 83.33% 63.64% 0.0% 0.0% 0.0%
Net Earnings $6.717B $6.552B $5.893B $7.264B $7.842B $8.394B $1.979B $7.722B $6.939B $5.158B $5.081B $4.345B $3.683B $4.627B $4.605B $4.052B $3.078B $2.950B $3.674B $2.363B $2.260B -$1.392B $1.120B $1.139B $1.096B $863.0M $644.0M $680.0M $538.0M $320.0M $383.0M $358.0M $98.00M $4.000M $4.000M -$8.000M $2.000M $1.000M $1.000M -$8.000M -$5.000M -$7.000M
YoY Change 2.52% 11.18% -18.87% -7.37% -6.58% 324.15% -74.37% 11.28% 34.53% 1.52% 16.94% 17.97% -20.4% 0.48% 13.65% 31.64% 4.34% -19.71% 55.48% 4.56% -262.36% -224.29% -1.67% 3.92% 27.0% 34.01% -5.29% 26.39% 68.13% -16.45% 6.98% 265.31% 2350.0% 0.0% -150.0% -500.0% 100.0% 0.0% -112.5% 60.0% -28.57%
Net Earnings / Revenue 23.83% 24.89% 22.68% 28.57% 33.57% 35.35% 8.66% 33.59% 32.03% 25.71% 27.21% 25.17% 23.64% 30.74% 31.45% 27.01% 20.84% 20.68% 29.56% 22.4% 27.05% -25.2% 27.89% 31.39% 32.81% 31.75% 26.82% 30.36% 27.73% 19.42% 27.87% 32.75% 14.37% 1.34% 2.7% -11.43% 4.55% 3.33% 4.35% -80.0% -166.67%
Basic Earnings Per Share $12.56 $12.18 $10.34 $12.40 $12.96 $12.70 $2.71 $10.32 $9.15 $6.80 $6.75 $5.61 $4.07 $4.82
Diluted Earnings Per Share $12.49 $12.11M $10.28 $12.31 $12.88 $12.62 $2.69 $10.24 $9.06 $6.70 $6.64 $5.52 $4.04 $4.79 $4.510M $3.769M $2.741M $2.479M $2.921M $1.790M $1.679M -$1.206M $1.033M $1.050M $1.017M $816.5K $586.0K $605.0K $471.5K $283.4K $331.6K $302.9K $82.49K $3.781K $4.884K -$9.913K $2.404K $1.395K $1.789K -$15.44K -$11.60K -$63.06K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982
Cash & Short-Term Investments $10.94B $9.305B $8.037B $10.65B $8.911B $29.30B $41.68B $38.09B $31.38B $27.03B $19.40B $24.06B $20.64B $17.42B $13.44B $9.552B $7.151B $6.277B $5.255B $5.808B $5.123B $4.664B $2.662B $2.028B $1.333B $1.276B $1.027B $1.077B $1.050B $697.0M $723.0M $555.0M $378.0M $170.0M $80.00M $66.00M $106.0M $58.00M $67.00M $22.00M $38.00M $5.000M
YoY Change 17.61% 15.78% -24.51% 19.48% -69.59% -29.69% 9.43% 21.36% 16.12% 39.3% -19.37% 16.57% 18.48% 29.61% 40.72% 33.58% 13.92% 19.45% -9.52% 13.37% 9.84% 75.21% 31.26% 52.14% 4.47% 24.25% -4.64% 2.57% 50.65% -3.6% 30.27% 46.83% 122.35% 112.5% 21.21% -37.74% 82.76% -13.43% 204.55% -42.11% 660.0%
Cash & Equivalents $10.94B $9.305B $7.989B $6.266B $6.037B $6.945B $3.800B $3.241B $4.144B $3.731B $3.805B $3.257B $6.946B $3.287B $2.884B $1.774B $2.024B $1.283B $1.840B $1.526B $837.0M $1.852B $689.0M $227.0M $131.0M $201.0M $239.0M $169.0M $67.00M $211.0M $129.0M $92.00M $146.0M $55.00M $39.00M $21.00M $0.00 $1.000M $47.00M $3.000M $38.00M $5.000M
Short-Term Investments $0.00 $1.676B $48.00M $4.381B $2.874B $22.36B $37.88B $34.84B $27.24B $23.30B $15.60B $20.80B $13.70B $14.14B $10.56B $7.778B $5.127B $4.994B $3.415B $4.282B $4.286B $2.812B $1.973B $1.802B $1.202B $1.075B $787.0M $908.0M $984.0M $485.0M $595.0M $463.0M $231.0M $115.0M $41.00M $46.00M $105.0M $57.00M $19.00M $19.00M $0.00 $0.00
Other Short-Term Assets $2.602B $2.388B $1.423B $1.280B $1.888B $1.794B $1.727B $2.015B $1.703B $2.494B $2.250B $1.886B $1.572B $1.350B $1.161B $1.521B $1.698B $1.408B $953.0M $1.013B $558.0M $442.0M $344.0M $215.0M $136.0M $157.0M $139.0M $103.0M $116.0M $126.0M $92.00M $105.0M $83.00M $40.00M $38.00M $1.000M $0.00 $1.000M $1.000M $0.00 $0.00 $0.00
YoY Change 8.96% 67.81% 11.17% -32.2% 5.24% 3.88% -14.29% 18.32% -31.72% 10.84% 19.3% 19.97% 16.44% 16.28% -23.67% -10.42% 20.6% 47.74% -5.92% 81.54% 26.24% 28.49% 60.0% 58.09% -13.38% 12.95% 34.95% -11.21% -7.94% 36.96% -12.38% 26.51% 107.5% 5.26% 3700.0% -100.0% 0.0%
Inventory $9.518B $4.930B $4.086B $3.893B $3.584B $2.940B $2.834B $2.745B $2.435B $2.647B $3.019B $2.744B $2.484B $2.022B $2.220B $2.075B $2.091B $1.903B $1.258B $888.0M $713.0M $545.0M $356.0M $305.0M $184.0M $111.0M $109.0M $97.00M $89.00M $98.00M $75.00M $57.00M $40.00M $34.00M $31.00M $15.00M $1.000M $0.00 $0.00 $0.00 $0.00 $0.00
Prepaid Expenses
Receivables $7.268B $5.563B $4.895B $4.525B $4.057B $3.580B $3.237B $3.165B $2.995B $2.546B $2.697B $2.518B $2.896B $2.335B $2.109B $2.073B $2.101B $2.124B $1.769B $1.461B $1.008B $752.0M $497.0M $389.0M $412.0M $320.0M $269.0M $225.0M $199.0M $195.0M $164.0M $156.0M $88.00M $41.00M $34.00M $15.00M $12.00M $7.000M $3.000M $1.000M $1.000M $1.000M
Other Receivables $0.00 $0.00 $944.0M $799.0M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $30.33B $22.19B $19.39B $21.14B $18.44B $37.62B $49.48B $46.01B $38.52B $34.71B $27.37B $31.21B $27.59B $23.13B $18.93B $15.22B $13.04B $11.71B $9.235B $9.170B $7.402B $6.404B $3.859B $2.937B $2.065B $1.863B $1.544B $1.503B $1.454B $1.116B $1.055B $873.0M $590.0M $285.0M $182.0M $98.00M $119.0M $65.00M $70.00M $24.00M $39.00M $6.000M
YoY Change 36.72% 14.45% -8.32% 14.66% -50.98% -23.97% 7.53% 19.46% 10.95% 26.84% -12.31% 13.1% 19.3% 22.17% 24.38% 16.72% 11.35% 26.82% 0.71% 23.89% 15.58% 65.95% 31.39% 42.23% 10.84% 20.66% 2.73% 3.37% 30.29% 5.78% 20.85% 47.97% 107.02% 56.59% 85.71% -17.65% 83.08% -7.14% 191.67% -38.46% 550.0%
Property, Plant & Equipment $5.941B $5.427B $5.750B $5.297B $5.397B $4.958B $4.989B $4.961B $4.907B $5.223B $5.349B $5.326B $5.420B $5.522B $5.738B $5.879B $5.941B $5.921B $5.038B $4.712B $3.799B $2.814B $1.946B $1.782B $1.554B $1.450B $1.186B $911.0M $744.0M $665.0M $587.0M $426.0M $246.0M $150.0M $119.0M $109.0M $55.00M $23.00M $14.00M $12.00M $8.000M $5.000M
YoY Change 9.47% -5.62% 8.55% -1.85% 8.85% -0.62% 0.56% 1.1% -6.05% -2.36% 0.43% -1.73% -1.85% -3.76% -2.4% -1.04% 0.34% 17.53% 6.92% 24.03% 35.0% 44.6% 9.2% 14.67% 7.17% 22.26% 30.19% 22.45% 11.88% 13.29% 37.79% 73.17% 64.0% 26.05% 9.17% 98.18% 139.13% 64.29% 16.67% 50.0% 60.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $251.0M $249.0M $573.0M $1.176B $570.0M $501.0M $0.00 $3.412B $0.00 $400.0M $377.0M $306.0M $356.0M $292.0M $241.0M $180.0M $133.0M $121.0M $117.0M $110.0M $96.00M $82.00M $59.00M $55.00M $21.00M $19.00M $1.000M $0.00 $1.000M $1.000M $3.000M $3.000M $0.00 $0.00
YoY Change 0.8% -56.54% -51.28% 13.77% -100.0% -100.0% 6.1% 23.2% -14.04% 21.92% 21.16% 33.89% 9.92% 3.42% 6.36% 14.58% 17.07% 38.98% 7.27% 161.9% 10.53% 1800.0% -100.0% 0.0% -66.67% 0.0%
Other Assets $9.611B $5.899B $5.385B $4.055B $1.754B $1.698B $1.549B $1.124B $1.599B $1.592B $1.767B $1.133B $1.124B $894.0M $751.0M $644.0M $793.0M $865.0M $607.0M $781.0M $804.0M $566.0M $507.0M $681.0M $326.0M $238.0M $264.0M $243.0M $139.0M $131.0M $65.00M $20.00M $9.000M $6.000M $6.000M $0.00 $18.00M $8.000M $7.000M $9.000M $9.000M $0.00
YoY Change 62.93% 9.55% 32.8% 131.19% 3.3% 9.62% 37.81% -29.71% 0.44% -9.9% 55.96% 0.8% 25.73% 19.04% 16.61% -18.79% -8.32% 42.5% -22.28% -2.86% 42.05% 11.64% -25.55% 108.9% 36.97% -9.85% 8.64% 74.82% 6.11% 101.54% 225.0% 122.22% 50.0% 0.0% -100.0% 125.0% 14.29% -22.22% 0.0%
Total Long-Term Assets $66.82B $42.94B $41.78B $41.80B $41.27B $28.80B $30.48B $31.62B $32.93B $34.30B $38.76B $23.09B $21.28B $20.36B $20.70B $21.21B $21.60B $22.08B $20.06B $20.05B $18.71B $18.05B $2.584B $2.463B $2.013B $1.809B $1.566B $1.263B $979.0M $878.0M $711.0M $501.0M $276.0M $175.0M $126.0M $109.0M $74.00M $32.00M $24.00M $24.00M $16.00M $6.000M
YoY Change 55.64% 2.76% -0.06% 1.3% 43.3% -5.51% -3.6% -4.0% -3.97% -11.51% 67.86% 8.51% 4.52% -1.64% -2.4% -1.81% -2.17% 10.04% 0.05% 7.16% 3.65% 598.61% 4.91% 22.35% 11.28% 15.52% 23.99% 29.01% 11.5% 23.49% 41.92% 81.52% 57.71% 38.89% 15.6% 47.3% 131.25% 33.33% 0.0% 50.0% 166.67%
Total Assets $97.15B $65.12B $61.17B $62.95B $59.71B $66.42B $79.95B $77.63B $71.45B $69.01B $66.13B $54.30B $48.87B $43.49B $39.63B $36.43B $34.64B $33.79B $29.30B $29.22B $26.11B $24.46B $6.443B $5.400B $4.078B $3.672B $3.110B $2.766B $2.433B $1.994B $1.766B $1.374B $866.0M $460.0M $308.0M $207.0M $193.0M $97.00M $94.00M $48.00M $55.00M $12.00M
YoY Change
Accounts Payable $16.95B $14.10B $1.366B $1.421B $1.371B $1.207B $1.352B $917.0M $965.0M $1.212B $787.0M $905.0M $642.0M $716.0M $574.0M $504.0M $378.0M $555.0M $596.0M $507.0M $327.0M $255.0M $137.0M $143.0M $83.00M $122.0M $104.0M $75.00M $54.00M $30.00M $23.00M $38.00M $30.00M $7.000M $12.00M $8.000M $7.000M $3.000M $1.000M $1.000M $1.000M $1.000M
YoY Change 20.24% 931.92% -3.87% 3.65% 13.59% -10.72% 47.44% -4.97% -20.38% 54.0% -13.04% 40.97% -10.34% 24.74% 13.89% 33.33% -31.89% -6.88% 17.55% 55.05% 28.24% 86.13% -4.2% 72.29% -31.97% 17.31% 38.67% 38.89% 80.0% 30.43% -39.47% 26.67% 328.57% -41.67% 50.0% 14.29% 133.33% 200.0% 0.0% 0.0% 0.0%
Accrued Expenses $12.49B $10.19B $8.947B $8.295B $7.565B $6.948B $5.563B $4.964B $5.451B $4.372B $3.649B $3.780B $5.028B $3.366B $3.299B $3.382B $3.610B $3.532B $2.999B $2.477B $2.129B $1.152B $766.0M $619.0M $648.0M $660.0M $608.0M $450.0M $460.0M $406.0M $279.0M $271.0M $263.0M $70.00M $31.00M $4.000M $4.000M $2.000M $1.000M $1.000M $1.000M $0.00
YoY Change 22.55% 13.92% 7.86% 9.65% 8.88% 24.9% 12.07% -8.93% 24.68% 19.81% -3.47% -24.82% 49.38% 2.03% -2.45% -6.32% 2.21% 17.77% 21.07% 16.35% 84.81% 50.39% 23.75% -4.48% -1.82% 8.55% 35.11% -2.17% 13.3% 45.52% 2.95% 3.04% 275.71% 125.81% 675.0% 0.0% 100.0% 100.0% 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $123.0M $100.0M $100.0M $100.0M $100.0M $0.00 $0.00 $70.00M $100.0M $110.0M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.000M
YoY Change -100.0% 23.0% 0.0% 0.0% 0.0% -100.0% -30.0% -9.09% -100.0%
Long-Term Debt Due $1.443B $1.591B $87.00M $91.00M $2.953B $4.419B $1.152B $4.403B $2.247B $500.0M $2.505B $2.495B $84.00M $2.488B $0.00 $1.000B $2.000B $1.798B $0.00 $1.173B $0.00 $0.00 $6.000M $30.00M $118.0M $0.00 $0.00 $0.00 $2.000M $2.000M $2.000M $2.000M $2.000M $2.000M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -9.3% 1728.74% -4.4% -96.92% -33.17% 283.59% -73.84% 95.95% 349.4% -80.04% 0.4% 2870.24% -96.62% -100.0% -50.0% 11.23% -100.0% -100.0% -80.0% -74.58% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Short-Term Liabilities $18.39B $15.69B $12.18B $11.65B $12.84B $13.49B $9.020B $11.20B $8.664B $7.008B $7.947B $8.191B $5.754B $6.570B $3.873B $4.886B $6.179B $6.942B $3.595B $4.157B $2.456B $1.529B $1.003B $862.0M $831.0M $887.0M $742.0M $643.0M $584.0M $536.0M $412.0M $311.0M $295.0M $87.00M $55.00M $15.00M $13.00M $6.000M $5.000M $2.000M $2.000M $1.000M
YoY Change 17.24% 28.75% 4.56% -9.21% -4.84% 49.53% -19.49% 29.32% 23.63% -11.82% -2.98% 42.35% -12.42% 69.64% -20.73% -20.93% -10.99% 93.1% -13.52% 69.26% 60.63% 52.44% 16.36% 3.73% -6.31% 19.54% 15.4% 10.1% 8.96% 30.1% 32.48% 5.42% 239.08% 58.18% 266.67% 15.38% 116.67% 20.0% 150.0% 0.0% 100.0%
Long-Term Debt $63.17B $37.35B $33.22B $32.90B $26.95B $29.51B $34.19B $30.19B $29.18B $30.22B $29.62B $24.03B $21.34B $10.87B $10.60B $8.352B $9.177B $7.214B $3.957B $3.937B $3.080B $3.048B $223.0M $223.0M $223.0M $223.0M $229.0M $59.00M $177.0M $183.0M $181.0M $130.0M $40.00M $63.00M $65.00M $30.00M $17.00M $7.000M $8.000M $8.000M $8.000M $0.00
YoY Change 69.11% 12.44% 0.99% 22.06% -8.68% -13.69% 13.24% 3.46% -3.42% 2.0% 23.25% 12.6% 96.28% 2.58% 26.93% -8.99% 27.21% 82.31% 0.51% 27.82% 1.05% 1266.82% 0.0% 0.0% 0.0% -2.62% 288.14% -66.67% -3.28% 1.1% 39.23% 225.0% -36.51% -3.08% 116.67% 76.47% 142.86% -12.5% 0.0% 0.0%
Other Long-Term Liabilities $7.006B $8.419B $9.059B $8.991B $9.643B $10.05B $10.34B $3.918B $3.281B $2.547B $2.961B $3.013B $2.744B $2.098B $2.488B $2.304B $934.0M $301.0M $131.0M $128.0M $42.00M $0.00 $157.0M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -16.78% -7.06% 0.76% -6.76% -4.09% -2.74% 163.83% 19.41% 28.82% -13.98% -1.73% 9.8% 30.79% -15.68% 7.99% 146.68% 210.3% 129.77% 2.34% 204.76% -100.0%
Total Long-Term Liabilities $70.18B $45.77B $42.28B $41.89B $36.59B $39.56B $44.53B $34.11B $32.46B $32.76B $32.58B $27.05B $24.09B $12.97B $13.09B $10.66B $10.11B $7.515B $4.088B $4.065B $3.122B $3.048B $223.0M $223.0M $223.0M $223.0M $229.0M $216.0M $177.0M $183.0M $181.0M $130.0M $40.00M $63.00M $65.00M $30.00M $17.00M $7.000M $8.000M $8.000M $8.000M $0.00
YoY Change 53.31% 8.26% 0.94% 14.46% -7.51% -11.15% 30.54% 5.08% -0.91% 0.55% 20.47% 12.28% 85.69% -0.89% 22.83% 5.39% 34.54% 83.83% 0.57% 30.2% 2.43% 1266.82% 0.0% 0.0% 0.0% -2.62% 6.02% 22.03% -3.28% 1.1% 39.23% 225.0% -36.51% -3.08% 116.67% 76.47% 142.86% -12.5% 0.0% 0.0%
Total Liabilities $90.92B $61.46B $54.47B $53.54B $50.03B $53.92B $54.71B $47.75B $43.37B $43.23B $44.03B $35.24B $29.84B $19.54B $16.96B $15.54B $16.77B $14.82B $8.846B $9.516B $6.724B $6.170B $1.226B $1.085B $1.054B $1.110B $971.0M $859.0M $761.0M $720.0M $594.0M $441.0M $334.0M $150.0M $120.0M $45.00M $29.00M $13.00M $13.00M $10.00M $10.00M $1.000M
YoY Change 47.94% 12.84% 1.73% 7.01% -7.2% -1.46% 14.58% 10.11% 0.31% -1.81% 24.95% 18.08% 52.71% 15.21% 9.14% -7.32% 13.13% 67.58% -7.04% 41.52% 8.98% 403.26% 13.0% 2.94% -5.05% 14.32% 13.04% 12.88% 5.69% 21.21% 34.69% 32.04% 122.67% 25.0% 166.67% 55.17% 123.08% 0.0% 30.0% 0.0% 900.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982
Basic Shares Outstanding 535.0M shares 538.0M shares 570.0M shares 586.0M shares 605.0M shares 661.0M shares 731.0M shares 748.0M shares 758.0M shares 759.0M shares 753.0M shares 775.0M shares 905.0M shares 960.0M shares
Diluted Shares Outstanding 538.0M shares 541.0M shares 573.0M shares 590.0M shares 609.0M shares 665.0M shares 735.0M shares 754.0M shares 766.0M shares 770.0M shares 765.0M shares 787.0M shares 912.0M shares 965.0M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $149.57 Billion

About AMGEN INC

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company is headquartered in Thousand Oaks, California and currently employs 26,700 full-time employees. The firm discovers, develops, manufactures and delivers various human therapeutics. The company focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. The company operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

Industry: Biological Products, (No Diagnostic Substances) Peers: AbbVie Inc. GILEAD SCIENCES, INC. Moderna, Inc. REGENERON PHARMACEUTICALS, INC. VERTEX PHARMACEUTICALS INC / MA